Inventor

MATHIAS JOHN PAUL

US30 patents

⚠️ This page may combine multiple inventors who share the name “MATHIAS JOHN PAUL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MATHIAS JOHN PAUL

PFIZER

Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3′,5′-monophosphate phosphodiesterase (cGMP-PDE5) for the treatment of sexual dysfunction

Bicyclic-fused heteroaryl or aryl compounds

Bicyclic-fused heteroaryl or aryl compounds

Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction

Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction

Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunction

Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunction

Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction

Pharmaceutically active compounds

Bicyclic-fused heteroaryl or aryl compounds

Nicotinamide derivatives useful as PDE4 inhibitors

Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3′,5′—monophosphate phosphodiesterase (cGMP PDE5) for the treatment of sexual dysfunction

Bicyclic-fused heteroaryl or aryl compounds

Bicyclic-fused heteroaryl or aryl compounds

Triazolopyridinylsulfanyl derivatives as p38 MAP kinase inhibitors

Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators

Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators

Quinazolinone compounds useful in therapy

Heterocyclic compounds as inhibitors of Vanin-1 enzyme

Nicotinamide derivatives useful as PDE4 inhibitors

Bicyclic-fused heteroaryl or aryl compounds

Process for preparing pharmaceutically active compounds

Tetrahydronaphthyridine derivatives

CYSTIC FIBROSIS FOUND THERAPEUTICS INC

Bicyclic heteroaryl derivatives as CFTR potentiators

Bicyclic heteroaryl derivatives as CFTR potentiators

Bicyclic heteroaryl derivatives as CFTR potentiators

Pyrrolopyrimidines as CFTR potentiators

CYSTIC FIBROSIS FOUND

Pyrrolopyrimidines as CFTR potentiators

Bicyclic heteroaryl derivatives as CFTR potentiators

MATHIAS JOHN PAUL

Triazolopyridinylsulfanyl derivatives as P38 map kinase inhibitors